Matthew Goff Investment Advisor’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.2M | Sell |
16,703
-119
| -0.7% | -$25.6K | 0.71% | 36 |
|
|
2026
Q1 | $3.66M | Sell |
16,822
-390
| -2% | -$86.5K | 0.61% | 42 |
|
|
2025
Q4 | $3.93M | Sell |
17,212
-349
| -2% | -$79.5K | 0.7% | 36 |
|
|
2025
Q3 | $4.07M | Buy |
17,561
+45
| +0.3% | +$9.16K | 0.69% | 36 |
|
|
2025
Q2 | $3.25M | Hold |
17,516
| – | – | 0.6% | 38 |
|
|
2025
Q1 | $3.67M | Sell |
17,516
-39
| -0.2% | -$7.58K | 0.68% | 39 |
|
|
2024
Q4 | $3.12M | Buy |
17,555
+97
| +0.6% | +$17.8K | 0.58% | 41 |
|
|
2024
Q3 | $3.45M | Sell |
17,458
-51
| -0.3% | -$9.52K | 0.66% | 36 |
|
|
2024
Q2 | $3M | Hold |
17,509
| – | – | 0.61% | 40 |
|
|
2024
Q1 | $3.19M | Buy |
17,509
+92
| +0.5% | +$15.9K | 0.65% | 38 |
|
|
2023
Q4 | $2.7M | Sell |
17,417
-110
| -0.6% | -$16K | 0.6% | 40 |
|
|
2023
Q3 | $2.61M | Sell |
17,527
-78
| -0.4% | -$11.5K | 0.63% | 39 |
|
|
2023
Q2 | $2.37M | Sell |
17,605
-67
| -0.4% | -$9.82K | 0.56% | 41 |
|
|
2023
Q1 | $2.82M | Sell |
17,672
-22
| -0.1% | -$3.36K | 0.7% | 37 |
|
|
2022
Q4 | $2.86M | Hold |
17,694
| – | – | 0.75% | 35 |
|
|
2022
Q3 | $2.38M | Sell |
17,694
-13
| -0.1% | -$1.86K | 0.68% | 34 |
|
|
2022
Q2 | $2.71M | Sell |
17,707
-391
| -2% | -$59.7K | 0.73% | 34 |
|
|
2022
Q1 | $2.93M | Sell |
18,098
-36
| -0.2% | -$5.23K | 0.69% | 33 |
|
|
2021
Q4 | $2.46M | Hold |
18,134
| – | – | 0.56% | 36 |
|
|
2021
Q3 | $1.96M | Sell |
18,134
-15
| -0.1% | -$1.71K | 0.48% | 38 |
|
|
2021
Q2 | $2.04M | Hold |
18,149
| – | – | 0.52% | 38 |
|
|
2021
Q1 | $1.96M | Sell |
18,149
-38
| -0.2% | -$4.07K | 0.55% | 39 |
|
|
2020
Q4 | $1.95M | Sell |
18,187
-439
| -2% | -$42.2K | 0.58% | 36 |
|
|
2020
Q3 | $1.63M | Sell |
18,626
-1,422
| -7% | -$134K | 0.52% | 40 |
|
|
2020
Q2 | $1.97M | Buy |
20,048
+39
| +0.2% | +$3.43K | 0.65% | 33 |
|
|
2020
Q1 | $1.52M | Sell |
20,009
-312
| -2% | -$26.6K | 0.64% | 33 |
|
|
2019
Q4 | $1.8M | Sell |
20,321
-25
| -0.1% | -$2.08K | 0.67% | 32 |
|
|
2019
Q3 | $1.54M | Sell |
20,346
-774
| -4% | -$53.1K | 0.64% | 33 |
|
|
2019
Q2 | $1.54M | Hold |
21,120
| – | – | 0.66% | 32 |
|
|
2019
Q1 | $1.7M | Hold |
21,120
| – | – | 0.79% | 29 |
|
|
2018
Q4 | $1.95M | Sell |
21,120
-294
| -1% | -$25.9K | 0.99% | 26 |
|
|
2018
Q3 | $2.02M | Sell |
21,414
-2,615
| -11% | -$248K | 0.81% | 36 |
|
|
2018
Q2 | $2.23M | Sell |
24,029
-6,374
| -21% | -$623K | 0.87% | 36 |
|
|
2018
Q1 | $2.88M | Sell |
30,403
-451
| -1% | -$49.5K | 1.21% | 31 |
|
|
2017
Q4 | $2.98M | Sell |
30,854
-1,440
| -4% | -$136K | 1.28% | 29 |
|
|
2017
Q3 | $2.87M | Sell |
32,294
-80
| -0.2% | -$6.09K | 1.23% | 30 |
|
|
2017
Q2 | $2.35M | Sell |
32,374
-2,587
| -7% | -$174K | 2.11% | 19 |
|
|
2017
Q1 | $2.28M | Buy |
+34,961
| New | +$2.2M | 2.18% | 18 |
|
Other funds holding ABBV
Matthew Goff Investment Advisor's ABBV Position: Q2 2026 in Review
Matthew Goff Investment Advisor reduced its AbbVie (ABBV) stake by 0.71% in Q2 2026, selling an estimated $25.6K and leaving 16,703 shares worth $4.2M. The position accounts for 0.71% of the portfolio, ranked #36.
Matthew Goff Investment Advisor first reported a position in ABBV in Q1 2017 and has held it in 38 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Matthew Goff Investment Advisor held 16,703 shares of AbbVie worth $4.2M as of Q2 2026.
- Matthew Goff Investment Advisor sold 119 AbbVie shares in Q2 2026, an estimated $25.6K.
- AbbVie made up 0.71% of Matthew Goff Investment Advisor's portfolio in Q2 2026, its #36 holding.
- Matthew Goff Investment Advisor first reported a position in AbbVie in Q1 2017 and has held it in 38 quarters since.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Matthew Goff Investment Advisor's 13F filing for Q2 2026, filed 8 Jul 2026.